Infectious Disease In-Vitro Diagnostics Market
According to Intent Market Research, the Infectious Disease In-Vitro Diagnostics Market is expected to grow from USD 5.2 Billion in 2024-e at a CAGR of 18.6% to touch USD 14.4 Billion by 2030. The Infectious Disease In-Vitro Diagnostics Market is dominated by key players such as Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, and Becton, Dickinson and Company.